+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Opioid-Induced Constipation Market 2020-2024 - Product Image

Global Opioid-Induced Constipation Market 2020-2024

  • ID: 5182679
  • Report
  • September 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AstraZeneca Plc
  • Daiichi Sankyo Co. Ltd.
  • Mallinckrodt Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Global Opioid-Induced Constipation Market 2020-2024

The opioid-induced constipation market is poised to grow by $ 3.39 bn during 2020-2024, progressing at a CAGR of 21% during the forecast period. The reports on the opioid-induced constipation market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increase in opioid prescriptions globally, a rise in the geriatric population, and the availability of reimbursements for opioid-based medications. In addition, an increase in opioid prescriptions globally is anticipated to boost the growth of the market as well.

The opioid-induced constipation market analysis includes the route of administration segment, class of drug, and geographical landscapes.

The opioid-induced constipation market is segmented as below:

By Route of Administration
  • Oral
  • Parenteral
By Class of Drugs
  • Peripherally acting mu-opioid receptor antagonists
  • Locally acting chloride channel activator
  • Others
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rise in the incidence of chronic diseases such as arthritis, back pain, and migraine as one of the prime reasons driving the opioid-induced constipation market growth during the next few years. Also, market dominance by opioid receptor antagonists and the introduction of separate diagnostic guidelines for idiopathic or functional constipation and opioid-induced constipation will lead to sizable demand in the market.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The report on the opioid-induced constipation market covers the following areas:
  • Opioid-induced constipation market sizing
  • Opioid-induced constipation market forecast
  • Opioid-induced constipation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading opioid-induced constipation market vendors that include AstraZeneca Plc, Bausch Health Companies Inc., Daiichi Sankyo Co. Ltd., Ironwood Pharmaceuticals Inc., Mallinckrodt Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., and Takeda Pharmaceutical Co. Ltd. Also, the opioid-induced constipation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AstraZeneca Plc
  • Daiichi Sankyo Co. Ltd.
  • Mallinckrodt Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market Ecosystem
  • Value Chain Analysis
Market Sizing
  • Market Definition
  • Market Segment Analysis
  • Market Size 2019
  • Market Outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Forces Summary
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of New Entrants
  • Threat of Substitutes
  • Threat of Rivalry
  • Market Condition
Market Segmentation by Route of Administration
  • Market Segments
  • Comparison by Route of Administration
  • Oral - Market Size and Forecast 2019-2024
  • Parenteral - Market Size and Forecast 2019-2024
  • Market Opportunity by Route of Administration
Market Segmentation by Class of Drugs
  • Peripherally Acting Mu-Opioid Receptor Antagonists
  • Locally Acting Chloride Channel Activator
  • Other Drugs
Customer Landscape
  • Overview
Geographic Landscape
  • Geographic Segmentation
  • Geographic Comparison
  • North America - Market Size and Forecast 2019-2024
  • Europe - Market Size and Forecast 2019-2024
  • Asia - Market Size and Forecast 2019-2024
  • Row - Market Size and Forecast 2019-2024
  • Key Leading Countries
  • Market Opportunity by Geography
  • Market Drivers
  • Market Challenges
  • Market Trends
Vendor Landscape
  • Overview
  • Landscape Disruption
Vendor Analysis
  • Vendors Covered
  • Market Positioning of Vendors
  • Astrazeneca plc
  • Bausch Health Companies Inc.
  • Daiichi Sankyo Co. Ltd.
  • Ironwood Pharmaceuticals Inc.
  • Mallinckrodt plc
  • Merck & Co. Inc.
  • Novartis Ag
  • Pfizer Inc.
  • Shionogi Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
Appendix
  • Scope of the Report
  • Currency Conversion Rates for US
  • Research Methodology
  • List of Abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent Market
10: Market Characteristics
11: Offerings of Vendors Included in the Market Definition
12: Market Segments
13: Global - Market Size and Forecast 2019 - 2024 ($ Million)
14: Global Market: Year-Over-Year Growth 2019 - 2024 (%)
15: Five Forces Analysis 2019 & 2024
16: Bargaining Power of Buyers
17: Bargaining Power of Suppliers
18: Threat of New Entrants
19: Threat of Substitutes
20: Threat of Rivalry
21: Market Condition - Five Forces 2019
22: Other1 - Market Share 2019-2024 (%)
23: Comparison by Other1
24: Oral - Market Size and Forecast 2019-2024 ($ Million)
25: Oral - Year-Over-Year Growth 2019-2024 (%)
26: Parenteral - Market Size and Forecast 2019-2024 ($ Million)
27: Parenteral - Year-Over-Year Growth 2019-2024 (%)
28: Market Opportunity by Other1
29: Other2 - Market Share 2019-2024 (%)
30: Comparison by Other2
31: Peripherally Acting Mu-Opioid Receptor Antagonists - Market Size and Forecast 2019-2024 ($ Million)
32: Peripherally Acting Mu-Opioid Receptor Antagonists - Year-Over-Year Growth 2019-2024 (%)
33: Locally Acting Chloride Channel Activator - Market Size and Forecast 2019-2024 ($ Million)
34: Locally Acting Chloride Channel Activator - Year-Over-Year Growth 2019-2024 (%)
35: Others - Market Size and Forecast 2019-2024 ($ Million)
36: Others - Year-Over-Year Growth 2019-2024 (%)
37: Market Opportunity by Other2
38: Customer Landscape
39: Market Share by Geography 2019-2024 (%)
40: Geographic Comparison
41: North America - Market Size and Forecast 2019-2024 ($ Million)
42: North America - Year-Over-Year Growth 2019-2024 (%)
43: Europe - Market Size and Forecast 2019-2024 ($ Million)
44: Europe - Year-Over-Year Growth 2019-2024 (%)
45: Asia - Market Size and Forecast 2019-2024 ($ Million)
46: Asia - Year-Over-Year Growth 2019-2024 (%)
47: Row - Market Size and Forecast 2019-2024 ($ Million)
48: Row - Year-Over-Year Growth 2019-2024 (%)
49: Key Leading Countries
50: Market Opportunity by Geography ($ Million)
51: Impact of Drivers and Challenges
52: Vendor Landscape
53: Landscape Disruption
54: Industry Risks
55: Vendors Covered
56: Market Positioning of Vendors
57: Astrazeneca plc - Overview
58: Astrazeneca plc - Product and Service
59: Astrazeneca plc - Key Offerings
60: Astrazeneca plc - Key Customers
61: Astrazeneca plc - Segment Focus
62: Bausch Health Companies Inc. - Overview
63: Bausch Health Companies Inc. - Business Segments
64: Bausch Health Companies Inc. - Key Offerings
65: Bausch Health Companies Inc. - Key Customers
66: Bausch Health Companies Inc. - Segment Focus
67: Daiichi Sankyo Co. Ltd. - Overview
68: Daiichi Sankyo Co. Ltd. - Business Segments
69: Daiichi Sankyo Co. Ltd. - Key Offerings
70: Daiichi Sankyo Co. Ltd. - Key Customers
71: Daiichi Sankyo Co. Ltd. - Segment Focus
72: Ironwood Pharmaceuticals Inc. - Overview
73: Ironwood Pharmaceuticals Inc. - Business Segments
74: Ironwood Pharmaceuticals Inc. - Key Offerings
75: Ironwood Pharmaceuticals Inc. - Key Customers
76: Ironwood Pharmaceuticals Inc. - Segment Focus
77: Mallinckrodt plc - Overview
78: Mallinckrodt plc - Business Segments
79: Mallinckrodt plc - Key Offerings
80: Mallinckrodt plc - Key Customers
81: Mallinckrodt plc - Segment Focus
82: Merck & Co. Inc. - Overview
83: Merck & Co. Inc. - Business Segments
84: Merck & Co. Inc. - Key Offerings
85: Merck & Co. Inc. - Key Customers
86: Merck & Co. Inc. - Segment Focus
87: Novartis AG - Overview
88: Novartis AG - Business Segments
89: Novartis AG - Key Offerings
90: Novartis AG - Key Customers
91: Novartis AG - Segment Focus
92: Pfizer Inc. - Overview
93: Pfizer Inc. - Business Segments
94: Pfizer Inc. - Key Offerings
95: Pfizer Inc. - Key Customers
96: Pfizer Inc. - Segment Focus
97: Shionogi Co. Ltd. - Overview
98: Shionogi Co. Ltd. - Business Segments
99: Shionogi Co. Ltd. - Key Offerings
100: Shionogi Co. Ltd. - Key Customers
101: Shionogi Co. Ltd. - Segment Focus
102: Takeda Pharmaceutical Co. Ltd. - Overview
103: Takeda Pharmaceutical Co. Ltd. - Product and Service
104: Takeda Pharmaceutical Co. Ltd. - Key Offerings
105: Takeda Pharmaceutical Co. Ltd. - Key Customers
106: Takeda Pharmaceutical Co. Ltd. - Segment Focus
107: Currency Conversion Rates for US
108: Research Methodology
109: Validation Techniques Employed for Market Sizing
110: Information Sources
111: List of Abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AstraZeneca Plc
  • Daiichi Sankyo Co. Ltd.
  • Mallinckrodt Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global opioid-induced constipation market: AstraZeneca Plc, Bausch Health Companies Inc., Daiichi Sankyo Co. Ltd., Ironwood Pharmaceuticals Inc., Mallinckrodt Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., and Takeda Pharmaceutical Co. Ltd.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the rise in incidence of chronic diseases such as arthritis, back pain, and migraine."

According to the report, one of the major drivers for this market is the increase in opioid prescriptions globally.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AstraZeneca Plc
  • Bausch Health Companies Inc.
  • Daiichi Sankyo Co. Ltd.
  • Ironwood Pharmaceuticals Inc.
  • Mallinckrodt Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • SHIONOGI Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll